[HTML][HTML] The role and therapeutic potential of NF-kappa-B pathway in severe COVID-19 patients

A Hariharan, AR Hakeem, S Radhakrishnan… - …, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) pandemic has affected health care systems
worldwide. Severe presentations of COVID-19 such as severe pneumonia and acute …

[HTML][HTML] Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?

SMR Hashemian, A Sheida, M Taghizadieh… - Biomedicine & …, 2023 - Elsevier
Despite the need for novel, effective therapeutics for the COVID-19 pandemic, no curative
regimen is yet available, therefore patients are forced to rely on supportive and nonspecific …

[HTML][HTML] Changes in food consumption during the COVID-19 pandemic: analysis of consumer survey data from the first lockdown period in Denmark, Germany, and …

M Janssen, BPI Chang, H Hristov, I Pravst… - Frontiers in …, 2021 - frontiersin.org
This paper focuses on changes in food consumption that occurred during the COVID-19
pandemic. Its objective is to map changes at individual consumer level and identify the …

[HTML][HTML] NF-κB pathway as a potential target for treatment of critical stage COVID-19 patients

R Kircheis, E Haasbach, D Lueftenegger… - Frontiers in …, 2020 - frontiersin.org
Patients infected with SARS-CoV-2 show a wide spectrum of clinical manifestations ranging
from mild febrile illness and cough up to acute respiratory distress syndrome, multiple organ …

Sex-related differences in long-COVID-19 syndrome

G Pelà, M Goldoni, E Solinas, C Cavalli… - Journal of Women's …, 2022 - liebertpub.com
Background: Sex differences have been demonstrated in the acute phase of coronavirus
disease 2019 (COVID-19). Women (F) were found to be less prone to develop a severe …

Mechanism of anosmia caused by symptoms of COVID-19 and emerging treatments

R Najafloo, J Majidi, A Asghari… - ACS Chemical …, 2021 - ACS Publications
The occurrence of anosmia, the loss or change in sense of smell, is one of the most common
symptoms of COVID-19 experienced by almost 53% of those affected. Several hypotheses …

[HTML][HTML] A survival analysis of COVID-19 in the Mexican population

G Salinas-Escudero, MF Carrillo-Vega… - BMC public health, 2020 - Springer
Abstract Background At present, the Americas report the largest number of cases of COVID-
19 worldwide. In this region, Mexico is the third country with most deaths (20,781 total …

[HTML][HTML] Neurobiochemical cross-talk between COVID-19 and Alzheimer's disease

MA Rahman, K Islam, S Rahman, M Alamin - Molecular neurobiology, 2021 - Springer
COVID-19, the global threat to humanity, shares etiological cofactors with multiple diseases
including Alzheimer's disease (AD). Understanding the common links between COVID-19 …

The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19

A Attiq, LJ Yao, S Afzal, MA Khan - International immunopharmacology, 2021 - Elsevier
Abstract The coronavirus disease (COVID-19) has once again reminded us of the
significance of host immune response and consequential havocs of the immune …

[HTML][HTML] Cognitive impairment in non-critical, mild-to-moderate COVID-19 survivors

AM Henneghan, KA Lewis, E Gill, SR Kesler - Frontiers in Psychology, 2022 - frontiersin.org
Importance Previous studies of post-acute COVID-19 syndrome have focused on critical
cases with severe disease. However, most cases are mild to moderate in disease severity …